Kidney Disease Clinical Trials

217 clinical trials for Kidney Disease across international registries, including 45 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy — RECRUITING · PHASE3
• Pedal Pump Clinical Trial on Edema V1 — RECRUITING · NA
• Immune System Related Kidney Disease — RECRUITING
• Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System — RECRUITING
• A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function — RECRUITING · PHASE1
• Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus — RECRUITING · NA
• Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation — RECRUITING · NA
• A randomized controlled, two-arm (1:1 ratio) Phase IIa trial to assess the efficacy and safety of obinutuzumab in treating adults with de novo minimal change disease — RECRUITING · PHASE2
• Adia Med of Winter Park LLC Chronic Kidney Disease Research Study — RECRUITING · PHASE1
• RaDIANT Health Systems Intervention — RECRUITING · NA
• Red Propolis Supplementation as a Strategy in Chronic Kidney Disease — RECRUITING · NA
• Direct to Patient Minimal Risk Biospecimen and Data Collection Research — RECRUITING
• Rutgers University Study of the Genetics of Kidney Disease — RECRUITING
• Renal and Hepatic Abnormal Doppler Patterns in Trauma — RECRUITING
• Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial — RECRUITING · NA
• Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD) — RECRUITING
• Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment — RECRUITING · NA
• Randomized Trial of SGLT2i in Heart Transplant Recipients — RECRUITING · PHASE4
• Inspire HER: Inspiring the Heart and Emotions for Radical Health — RECRUITING · NA
• Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN) — RECRUITING · NA
• Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation — RECRUITING
• A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population — RECRUITING
• A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation — RECRUITING
• PODOMOUNT-BASKET, A PHASE II, MULTICENTRE, RANDOMISED, 2-ARM PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED BASKET TRIAL TO ASSESS SAFETY, TOLERABILITY, PK, AND EFFICACY OF BI 764198 IN FOUR PROTEINURIC KIDNEY DISEASES — RECRUITING · PHASE2
• Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia — RECRUITING
• A PHASE 2A, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF VX-407 IN SUBJECTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WHO HAVE A SUBSET OF PKD1 GENE VARIANTS — RECRUITING · PHASE2
• DIALysis With EXpanded Solute Removal — RECRUITING · NA
• GENomic Predictors in A Multi-Ethnic Population With Kidney Disease Study — RECRUITING
• Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation — RECRUITING · NA
• Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps) — RECRUITING
• BIOmarkers Before and After Kidney Transplantation — RECRUITING
• Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial — RECRUITING
• BLEEDING REDUCTION IN ACUTE AND CHRONIC KIDNEY PATIENTS HAVING SURGERY (BRACKETS) PILOT TRIAL — RECRUITING
• A PHASE IIB, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, DOSE-FINDING STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF BALCINRENONE IN COMBINATION WITH DAPAGLIFLOZIN COMPARED WITH DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ALBUMINURIA — RECRUITING · PHASE2
• CANAGLIFLOZIN IN PATIENTS WITH ADVANCED RENAL DISEASE WITH MRI ENDPOINTS (CARE-MRI TRIAL) — RECRUITING
• A PHASE III, RANDOMISED, MULTICENTRE, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ZIBOTENTAN/DAPAGLIFLOZIN COMPARED TO DAPAGLIFLOZIN ALONE IN PARTICIPANTS WITH CHRONIC KIDNEY DISEASE AND HIGH PROTEINURIA — RECRUITING · PHASE3
• A PHASE 2B / 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, COMBINED DOSE-FINDING AND CARDIOVASCULAR OUTCOME STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF CSL300 IN SUBJECTS WITH END STAGE KIDNEY DISEASE UNDERGOING DIALYSIS — RECRUITING · PHASE2
• A PHASE 2/3 ADAPTIVE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VX-147 IN ADULT AND PEDIATRIC SUBJECTS WITH APOL1 MEDIATED PROTEINURIC KIDNEY DISEASE — RECRUITING · PHASE2
• A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY TO EVALUATE THE EFFICACV AND SAFETV OFMEDI3506 IN SUBJECTS WITH DIABETIC KIDNEY DISEASE — RECRUITING · PHASE2
• A PHASE 2, OPEN-LABEL, MULTIPLE DOSE STUDY TO EVALUATE THE PHARMACODYNAMIC EFFECTS, SAFETY AND TOLERABILITY OF PATIROMER FOR ORAL SUSPENSION IN CHILDREN AND ADOLESCENTS 2 TO < 18 YEARS OF AGE WITH CHRONIC KIDNEY DISEASE AND HYPERKALEMIA (EMERALD) — RECRUITING · PHASE2
• A PILOT STUDY OF CYSTIC VOLUME REDUCTION BY FOAM SCLEROTHERAPY IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QPI-1002 FOR THE PREVENTION OF ACUTE KIDNEY INJURY IN SUBJECTS AT HIGH RISK FOR AKI FOLLOWING CARDIAC SURGERY — RECRUITING · PHASE2
• A PHASE II/III RANDOMIZED CLINICAL TRIAL TO STUDY THE EFFICACY AND SAFETY OF THE COMBINATION REGIMEN OF MK-5172 AND MK-8742 IN SUBJECTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND CHRONIC KIDNEY DISEASE — RECRUITING
• A 24-WEEK, PHASE 2B, RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF GSK1278863 IN SUBJECTS WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE WHO ARE NOT ON DIALYSIS — RECRUITING · PHASE2
• A PHASE 2B, RANDOMIZED, BLINDED, DOSE-RANGING, ACTIVE-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY TO EVALUATE THE DOSE RESPONSE RELATIONSHIP OF GSK1278863 OVER THE FIRST 4 WEEKS OF TREATMENT AND EVALUATE THE SAFETY AND EFFICACY OF GSK1278863 OVER 24 WEEKS IN HEMODIALYSIS-DEPENDENT SUBJECTS WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE WHO SWITCH FROM RECOMBINANT HUMAN ERYTHROPOIETIN — RECRUITING · PHASE2
• Local and Systemic Inflammatory Bone Alterations Related to Dental Implant Survival. — ACTIVE_NOT_RECRUITING
• Team-Based Shared Decision-Making Program in Cardiovascular-Kidney-Metabolic Health — NOT_YET_RECRUITING · PHASE1
• ABO/Rh Blood Group Phenotypes as Predictor of Treatment Outcomes in Diabetic Kidney Disease — COMPLETED
• The Clinical Research of Traditional Chinese Medicine Formula — NOT_YET_RECRUITING · PHASE4
• The Effect of Patient Empowerment Learning (With AI) About Itching in Hemodylasis Patients. — ACTIVE_NOT_RECRUITING · NA

Refine this search